Feasibility and Clinical Utility of Ambulatory Ultraslow Deflation Sphygmomanometers in LVAD Recipients - easiSLOW-LVAD Pilot

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07633561

Acronym

easiSLOW-LVAD

Enrollment

Registered

2026-06-08

Start date

2026-08-01

Completion date

2028-02-01

Last updated

2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LVAD (Left Ventricular Assist Device)

Brief summary

Prospective, single-arm feasibility study will evaluate the use of an ultraslow deflation automated sphygmomanometer (Terumo Elemano 2) for home BP monitoring in patients with continuous-flow LVADs. Outcomes include patient-reported ability to obtain BP readings, adherence, ease of use, and correlation with clinical parameters. Findings may support improved BP monitoring strategies in this high-risk population.

Interventions

DEVICEUltraslow deflation cuff

Patients will be assigned to receive an ultraslow deflation syphgmomanometer for home blood pressure management

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* HM3 LVAD and age \> 18

Exclusion criteria

* eGFR \< 30 * bilateral limb alerts (inability to obtain upper extremity blood pressures) * ongoing inotropic support * cognitive or severe visual impairment * the use of an investigational LVAD * Durable biventricular support

Design outcomes

Primary

Measure	Time frame	Description
Ability to measure blood pressures	6 months	Successful BP measurement and recording

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026